PedAM
Pediatric Disease Annotations & Medicines
| Disease | antiphospholipid syndrome |
| Symptom | C0000809|recurrent miscarriage |
| Sentences | 6 |
| PubMedID- 24578841 | Also ghosh (17) in a prospective, observational study evaluated the prevalence of antiphospholipid syndrome among women with recurrent miscarriages/late pregnancy loss and 27.7% were positive for antiphospholipid antibodies but we found antiphospholipid rate in case and control groups was equal. |
| PubMedID- 20378110 | antiphospholipid syndrome patients with recurrent miscarriage have an impairment in fibrinolysis demonstrated by prolonged clot lysis time (clt) that cannot be attributed to differences in thrombin activatable fibrinolysis inhibitor (tafi) antigen levels. |
| PubMedID- 20795446 | This retrospective review of hospital records analysed pregnancy outcome with 2 different treatments for women with recurrent miscarriage diagnosed with antiphospholipid syndrome in the index pregnancy. |
| PubMedID- 25395740 | Therefore, it is recommended treatment for recurrent miscarriages with antiphospholipid syndrome (evidence level i). |
| PubMedID- 23043688 | Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage. |
| PubMedID- 20393166 | Antiphospholipid antibodies (apl) represent an important risk factor for thrombosis and recurrent miscarriage in patients with antiphospholipid syndrome (aps). |
Page: 1